CV Sciences (CVSI) Gross Margin (2013 - 2026)
CV Sciences' (CVSI) quarterly Gross Margin came in at 48.89% in Q1 2026, up 291.0% year-on-year from 12.5% in Q1 2025, and down 3.25% quarter-over-quarter from 50.53% in Q4 2025.
CV Sciences (CVSI) Gross Margin (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Gross Margin across 14 years of filings, most recently posting 48.89% for Q1 2026.
- Gross Margin for Q1 2026 came in at 48.89%, up 291.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 49.75% (up 420.0% YoY), and the FY2025 annual result was 48.97%, up 333.0% from the prior year.
- Gross Margin came in at 48.89% for Q1 2026 at CV Sciences, down from 50.53% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 50.94% in Q2 2025 to a low of 26.0% in Q1 2022.
- The 5-year median for Gross Margin is 45.83% (2023), against an average of 43.72%.
- Across the five-year window, Gross Margin plunged 2268 bps in 2022 and soared 1697 bps in 2023, its largest moves.
- CV Sciences' Gross Margin stood at 40.37% in 2022, then increased by 14 bps to 45.83% in 2023, then retreated by 6 bps to 43.18% in 2024, then rose by 17 bps to 50.53% in 2025, then declined by 3 bps to 48.89% in 2026.
- The last three Gross Margin figures came in at 48.89% (Q1 2026), 50.53% (Q4 2025), and 48.5% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | CV Sciences | - | - | 1.56 Mn | 48.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.89% |
| Dec 31, 2025 | 50.53% |
| Sep 30, 2025 | 48.50% |
| Jun 30, 2025 | 50.94% |
| Mar 31, 2025 | 45.98% |
| Dec 31, 2024 | 43.18% |
| Sep 30, 2024 | 46.00% |
| Jun 30, 2024 | 47.04% |
| Mar 31, 2024 | 46.30% |
| Dec 31, 2023 | 45.83% |
| Sep 30, 2023 | 45.07% |
| Jun 30, 2023 | 43.32% |
| Mar 31, 2023 | 42.96% |
| Dec 31, 2022 | 40.37% |
| Sep 30, 2022 | 41.64% |
| Jun 30, 2022 | 30.69% |
| Mar 31, 2022 | 26.00% |
| Dec 31, 2021 | 32.40% |
| Sep 30, 2021 | 46.17% |
| Jun 30, 2021 | 44.66% |